Your browser doesn't support javascript.
loading
VEGF-C-expressing TAMs rewire the metastatic fate of breast cancer cells.
Banerjee, Kaveri; Kerzel, Thomas; Bekkhus, Tove; de Souza Ferreira, Sabrina; Wallmann, Tatjana; Wallerius, Majken; Landwehr, Laura-Sophie; Agardy, Dennis Alexander; Schauer, Nele; Malmerfeldt, Anna; Bergh, Jonas; Bartish, Margarita; Hartman, Johan; Östman, Arne; Squadrito, Mario Leonardo; Rolny, Charlotte.
Afiliação
  • Banerjee K; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Kerzel T; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; Vita Salute San Raffaele University, 20132 Milan, Italy.
  • Bekkhus T; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • de Souza Ferreira S; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Wallmann T; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Wallerius M; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Landwehr LS; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Agardy DA; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Schauer N; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Malmerfeldt A; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Bergh J; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden; Breast Center, Karolinska Comprehensive Cancer Center and Karolinska University Hospital, 17176 Stockholm, Sweden.
  • Bartish M; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden; Gerald Bronfman Department of Oncology, Segal Cancer Centre, Lady Davis Institute and Jewish General Hospital, McGill University, Montreal, QC H3T 1E2, Canada.
  • Hartman J; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, 17176 Stockholm, Sweden.
  • Östman A; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden.
  • Squadrito ML; San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, 20132 Milan, Italy; Vita Salute San Raffaele University, 20132 Milan, Italy. Electronic address: squadrito.mario@hsr.it.
  • Rolny C; Department of Oncology-Pathology, Karolinska Institutet, 17164 Stockholm, Sweden. Electronic address: charlotte.rolny@ki.se.
Cell Rep ; 42(12): 113507, 2023 12 26.
Article em En | MEDLINE | ID: mdl-38041815
ABSTRACT
The expression of pro-lymphangiogenic VEGF-C in primary tumors is associated with sentinel lymph node metastasis in most solid cancer types. However, the impact of VEGF-C on distant organ metastasis remains unclear. Perivascular tumor-associated macrophages (TAMs) play a crucial role in guiding hematogenous spread of cancer cells by establishing metastatic pathways within the tumor microenvironment. This process supports breast cancer cell intravasation and metastatic dissemination. We show here that VEGF-C-expressing TAMs reduce the dissemination of mammary cancer cells to the lungs while concurrently increasing lymph node metastasis. These TAMs express podoplanin and interact with normalized tumor blood vessels expressing VEGFR3. Moreover, clinical data suggest inverse association between VEGF-C-expressing TAMs and breast cancer malignancy. Thus, our study elucidates the paradoxical role of VEGF-C-expressing TAMs in redirecting cancer cells to preferentially disseminate to lymph nodes rather than to lungs, partially achieved by normalizing tumor blood vessels and promoting lymphangiogenesis.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article